210 related articles for article (PubMed ID: 36806439)
21. Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study.
Parker WH; Broder MS; Chang E; Feskanich D; Farquhar C; Liu Z; Shoupe D; Berek JS; Hankinson S; Manson JE
Obstet Gynecol; 2009 May; 113(5):1027-1037. PubMed ID: 19384117
[TBL] [Abstract][Full Text] [Related]
22. Options for hormone therapy in women who have had a hysterectomy.
Haney AF; Wild RA
Menopause; 2007; 14(3 Pt 2):592-7; quiz 598-9. PubMed ID: 17476150
[TBL] [Abstract][Full Text] [Related]
23. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women.
Stanford JL; Weiss NS; Voigt LF; Daling JR; Habel LA; Rossing MA
JAMA; 1995 Jul; 274(2):137-42. PubMed ID: 7596001
[TBL] [Abstract][Full Text] [Related]
24. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
Glass AG; Lacey JV; Carreon JD; Hoover RN
J Natl Cancer Inst; 2007 Aug; 99(15):1152-61. PubMed ID: 17652280
[TBL] [Abstract][Full Text] [Related]
25. Increased cardiovascular mortality after early bilateral oophorectomy.
Rivera CM; Grossardt BR; Rhodes DJ; Brown RD; Roger VL; Melton LJ; Rocca WA
Menopause; 2009; 16(1):15-23. PubMed ID: 19034050
[TBL] [Abstract][Full Text] [Related]
26. Oophorectomy, hormone therapy, and subclinical coronary artery disease in women with hysterectomy: the Women's Health Initiative coronary artery calcium study.
Allison MA; Manson JE; Langer RD; Carr JJ; Rossouw JE; Pettinger MB; Phillips L; Cochrane BB; Eaton CB; Greenland P; Hendrix S; Hsia J; Hunt JR; Jackson RD; Johnson KC; Kuller LH; Robinson J;
Menopause; 2008; 15(4 Pt 1):639-47. PubMed ID: 18458645
[TBL] [Abstract][Full Text] [Related]
27. Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk?
Trabert B; Wentzensen N; Yang HP; Sherman ME; Hollenbeck AR; Park Y; Brinton LA
Int J Cancer; 2013 Jan; 132(2):417-26. PubMed ID: 22553145
[TBL] [Abstract][Full Text] [Related]
28. Menopausal hormone therapy and cancer: changing clinical observations of target site specificity.
Chlebowski RT; Anderson GL
Steroids; 2014 Nov; 90():53-9. PubMed ID: 24910928
[TBL] [Abstract][Full Text] [Related]
29. Ovarian removal and subsequent breast cancer prognosis: a nationwide cohort study.
Gottschau M; Kjær SK; Viuff JH; Jensen A; Munk C; Settnes A; Mellemkjær L
Breast Cancer Res Treat; 2023 Feb; 197(3):583-591. PubMed ID: 36482232
[TBL] [Abstract][Full Text] [Related]
30. Hysterectomy, Oophorectomy, and Risk of Renal Cell Carcinoma.
Luo J; Rohan TE; Neuhouser ML; Liu N; Saquib N; Li Y; Shadyab AH; Qi L; Wallace RB; Hendryx M
Cancer Epidemiol Biomarkers Prev; 2021 Mar; 30(3):499-506. PubMed ID: 33335021
[TBL] [Abstract][Full Text] [Related]
31. Hysterectomy with and without oophorectomy and all-cause and cause-specific mortality.
Tuesley KM; Protani MM; Webb PM; Dixon-Suen SC; Wilson LF; Stewart LM; Jordan SJ
Am J Obstet Gynecol; 2020 Nov; 223(5):723.e1-723.e16. PubMed ID: 32376318
[TBL] [Abstract][Full Text] [Related]
32. Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials.
Chlebowski RT; Anderson GL; Aragaki AK; Manson JE; Stefanick ML; Pan K; Barrington W; Kuller LH; Simon MS; Lane D; Johnson KC; Rohan TE; Gass MLS; Cauley JA; Paskett ED; Sattari M; Prentice RL
JAMA; 2020 Jul; 324(4):369-380. PubMed ID: 32721007
[TBL] [Abstract][Full Text] [Related]
33. Menopause, hysterectomy, menopausal hormone therapy and cause-specific mortality: cohort study of UK Biobank participants.
Xu Z; Chung HF; Dobson AJ; Wilson LF; Hickey M; Mishra GD
Hum Reprod; 2022 Aug; 37(9):2175-2185. PubMed ID: 35690930
[TBL] [Abstract][Full Text] [Related]
34. Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women.
Chlebowski RT; Anderson GL; Gass M; Lane DS; Aragaki AK; Kuller LH; Manson JE; Stefanick ML; Ockene J; Sarto GE; Johnson KC; Wactawski-Wende J; Ravdin PM; Schenken R; Hendrix SL; Rajkovic A; Rohan TE; Yasmeen S; Prentice RL;
JAMA; 2010 Oct; 304(15):1684-92. PubMed ID: 20959578
[TBL] [Abstract][Full Text] [Related]
35. Hysterectomy status and all-cause mortality in a 21-year Australian population-based cohort study.
Wilson LF; Pandeya N; Byles J; Mishra GD
Am J Obstet Gynecol; 2019 Jan; 220(1):83.e1-83.e11. PubMed ID: 30312584
[TBL] [Abstract][Full Text] [Related]
36. Examining indicators of early menopause following opportunistic salpingectomy: a cohort study from British Columbia, Canada.
Hanley GE; Kwon JS; McAlpine JN; Huntsman DG; Finlayson SJ; Miller D
Am J Obstet Gynecol; 2020 Aug; 223(2):221.e1-221.e11. PubMed ID: 32067967
[TBL] [Abstract][Full Text] [Related]
37. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk.
Schairer C; Lubin J; Troisi R; Sturgeon S; Brinton L; Hoover R
JAMA; 2000 Jan; 283(4):485-91. PubMed ID: 10659874
[TBL] [Abstract][Full Text] [Related]
38. Ovarian cancer incidence and death in average-risk women undergoing bilateral salpingo-oophorectomy at benign hysterectomy.
Cusimano MC; Ferguson SE; Moineddin R; Chiu M; Aktar S; Liu N; Baxter NN
Am J Obstet Gynecol; 2022 Feb; 226(2):220.e1-220.e26. PubMed ID: 34563499
[TBL] [Abstract][Full Text] [Related]
39. Association of Fibroids, Endometriosis, and Gynecologic Surgeries with Breast Cancer Incidence and Hormone Receptor Subtypes.
Zeldin J; Sandler DP; Ogunsina K; O'Brien KM
Cancer Epidemiol Biomarkers Prev; 2024 Apr; 33(4):576-585. PubMed ID: 38260971
[TBL] [Abstract][Full Text] [Related]
40. Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease.
Popat RA; Van Den Eeden SK; Tanner CM; McGuire V; Bernstein AL; Bloch DA; Leimpeter A; Nelson LM
Neurology; 2005 Aug; 65(3):383-90. PubMed ID: 16087902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
